(CHPG sodium salt is a selective mGluR5 agonist that attenuates SO₂-induced oxidative stress and inflammation in BV2 microglial cells via the TSG-6/NF-κB pathway; it prevents traumatic brain injury (TBI) both in vitro and in vivo through the ERK and Akt signaling pathways; it significantly increases cell viability, decreases LDH release, and protects against SO₂-induced apoptosis in BV2 cells; it upregulates TSG-6 expression at both mRNA and protein levels; in vivo, it significantly reduces cerebral lesion volume in a rat model of TBI following intracerebral injection.)